BlackRock, Inc. 13D and 13G filings for Intercept Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Purchase |
2023-06-30 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
BlackRock Inc. BLK |
4,396,970 10.500% |
1,312,137 (+42.54%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
BlackRock Inc. BLK |
3,084,833 7.400% |
852,741 (+38.20%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
BlackRock Inc. BLK |
2,232,092 7.600% |
-266,316 (-10.66%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
BlackRock Inc. BLK |
2,498,408 7.600% |
183,940 (+7.95%) |
Filing |